एपीए उद्धरण

Helbig, G., Bober, G., Seweryn, M., Wichary, R., Tukiendorf, A., Sedlak, L., . . . Kyrcz-Krzemień, S. (2015). Occurrence of Secondary Malignancies in Chronic Myeloid Leukemia During Therapy with Imatinib Mesylate-Single Institution Experience. Mediterr J Hematol Infect Dis.

शिकागो स्टाइल उद्धरण

Helbig, Grzegorz, Grażyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, और Sławomira Kyrcz-Krzemień. "Occurrence of Secondary Malignancies in Chronic Myeloid Leukemia During Therapy With Imatinib Mesylate-Single Institution Experience." Mediterr J Hematol Infect Dis 2015.

एमएलए उद्धरण

Helbig, Grzegorz, et al. "Occurrence of Secondary Malignancies in Chronic Myeloid Leukemia During Therapy With Imatinib Mesylate-Single Institution Experience." Mediterr J Hematol Infect Dis 2015.